These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

449 related items for PubMed ID: 16146553

  • 1. Is alanine aminotransferase a good marker of histologic hepatic damage in renal transplant patients with hepatitis C virus infection?
    Perez RM, Ferreira AS, Medina-Pestana JO, Lanzoni VP, Silva AE, Ferraz ML.
    Clin Transplant; 2005 Oct; 19(5):622-5. PubMed ID: 16146553
    [Abstract] [Full Text] [Related]

  • 2. Is serum alanine transaminase level a reliable marker of histological disease in chronic hepatitis C infection?
    Sanai FM, Benmousa A, Al-Hussaini H, Ashraf S, Alhafi O, Abdo AA, Alameri HF, Akbar HO, Bzeizi KI.
    Liver Int; 2008 Aug; 28(7):1011-8. PubMed ID: 18384520
    [Abstract] [Full Text] [Related]

  • 3. Chronic hepatitis C infection in patients with end stage renal disease: characterization of liver histology and viral load in patients awaiting renal transplantation.
    Sterling RK, Sanyal AJ, Luketic VA, Stravitz RT, King AL, Post AB, Mills AS, Contos MJ, Shiffman ML.
    Am J Gastroenterol; 1999 Dec; 94(12):3576-82. PubMed ID: 10606322
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK, Bansal SB, Gupta A, Gulati S, Kumar A, Prasad N.
    Clin Transplant; 2006 Dec; 20(6):677-83. PubMed ID: 17100715
    [Abstract] [Full Text] [Related]

  • 6. Hepatitis C virus infection in renal transplant patients: a comparative study with immunocompetent patients.
    Perez RM, Ferreira AS, Silva IS, Medina-Pestana JO, Lanzoni VP, Silva AE, Ferraz ML.
    Clin Transplant; 2005 Dec; 19(6):763-8. PubMed ID: 16313322
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Hepatitis C virus infection acquired in childhood.
    Camarero C, Ramos N, Moreno A, Asensio A, Mateos ML, Roldan B.
    Eur J Pediatr; 2008 Feb; 167(2):219-24. PubMed ID: 17464514
    [Abstract] [Full Text] [Related]

  • 12. Determination of the cut-off value of serum alanine aminotransferase in patients undergoing hemodialysis, to identify biochemical activity in patients with hepatitis C viremia.
    Lopes EP, Gouveia EC, Albuquerque AC, Sette LH, Mello LA, Moreira RC, Coelho MR.
    J Clin Virol; 2006 Mar; 35(3):298-302. PubMed ID: 16290052
    [Abstract] [Full Text] [Related]

  • 13. Prospective study on anti-hepatitis C virus-positive patients with persistently normal serum alanine transaminase with or without detectable serum hepatitis C virus RNA.
    Martinot-Peignoux M, Boyer N, Cazals-Hatem D, Pham BN, Gervais A, Le Breton V, Levy S, Degott C, Valla DC, Marcellin P.
    Hepatology; 2001 Nov; 34(5):1000-5. PubMed ID: 11679971
    [Abstract] [Full Text] [Related]

  • 14. Clinical features of hepatitis C-infected patients with persistently normal alanine transaminase levels in the Southwestern United States.
    Jamal MM, Soni A, Quinn PG, Wheeler DE, Arora S, Johnston DE.
    Hepatology; 1999 Nov; 30(5):1307-11. PubMed ID: 10534355
    [Abstract] [Full Text] [Related]

  • 15. Interferon monotherapy for patients with chronic hepatitis C and normal serum aminotransferase levels at commencement of treatment.
    Mamori S, Suzuki F, Hosaka T, Akuta N, Someya T, Kobayashi M, Tsubota A, Suzuki Y, Saitoh S, Arase Y, Ikeda K, Kumada H.
    J Gastroenterol; 2004 Aug; 39(8):776-82. PubMed ID: 15338372
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Clinical, histological, and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levels.
    Puoti C, Magrini A, Stati T, Rigato P, Montagnese F, Rossi P, Aldegheri L, Resta S.
    Hepatology; 1997 Dec; 26(6):1393-8. PubMed ID: 9397976
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Chronic hepatitis C in patients with persistently normal alanine transaminase levels.
    Shiffman ML, Diago M, Tran A, Pockros P, Reindollar R, Prati D, Rodríguez-Torres M, Lardelli P, Blotner S, Zeuzem S.
    Clin Gastroenterol Hepatol; 2006 May; 4(5):645-52. PubMed ID: 16630770
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.